Part 3: AASLD TLMdX 2020

ARE YOU A PATIENT LIVING WITH NAFLD/NASH OR HEALTHCARE PROFESSIONAL CARING FOR NAFLD/NASH PATIENTS?

Welcome to Fatty Liver Foundation's LIVER (Live Interactive Virtual Education and Review) Webinar Series. This four-part webinar series will deliver the latest research and medical information to people living with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) and their medical providers. Our goal is to keep the patient community up-to-date on medical research and to build an archive of the important historical evolution of the field.

FLF believes independent, clear, timely, and accurate information is vital for empowering patients to help them develop self-awareness, self-care, make informed decisions about participating in clinical trials, and promote understanding that patients can be equal partners in their healthcare decisions.

Are you ready to join us for part-three of the FLF LIVER Webinar Series? Our expert faculty will review and discuss highlights from the AASLD The Liver Meeting Digital Experience (TLMdX) 2020 and answer your questions.

We look forward to your participation!

Host: Wayne Eskridge, Co-Founder and CEO, Fatty Liver Foundation
Moderator: Neeraj Mistry, MD, MPH, Chief Medical Officer, Fatty Liver Foundation

Contact us at [email protected] if you have any questions.

AGENDA*

12:00 pm – 12:10 pm

WELCOME AND INTRODUCTION

Host – Wayne Eskridge, Fatty Liver Foundation

Moderator – Neeraj Mistry, MD, MPH, Fatty Liver Foundation

12:10 pm – 12:30 pm

SESSION 1: LIFESTYLE AND DIET

New Data on Lifestyle and Dietary Interventions in NAFLD/NASH Management

Presenter – Meagan Gray, MD, University of Alabama at Birmingham

Q&A – Neeraj Mistry, MD, MPH, Fatty Liver Foundation

12:30 pm – 12:50 pm

SESSION 2: TESTING

Advances in Non-Invasive Biomarkers for Diagnosis and Monitoring of NAFLD/NASH

Presenter – Meena Bansal, MD, Icahn School of Medicine at Mount Sinai, 

Population Health for Quality and Efficiency Mount Sinai Health Partners

Q&A – Neeraj Mistry, MD, MPH, Fatty Liver Foundation

12:50 pm – 01:10 pm

SESSION 3: TREATMENT

Update on Investigational Drugs and Therapeutic Targets for NAFLD/NASH

Presenter – Raymond Chung, MD, Harvard Medical School, Massachusetts General Hospital

Q&A – Neeraj Mistry, MD, MPH, Fatty Liver Foundation

01:10 pm – 01:15 pm

REFLECTIONS AND TAKEAWAY POINTS

Wayne Eskridge, Fatty Liver Foundation

 

*Subject to change. This educational program is supported by grants from Intercept Pharmaceuticals, Madrigal Pharmaceuticals, and NetNoggin. Fatty Liver Foundation maintains editorial control and independence over the educational program content.

 

CLICK HERE to view the recording of LIVER 3


Click for our online community

connect